NQMC Update Service: April 22, 2013 ▲ Australian Council on Healthcare Standards

NQMC Update Service: April 22, 2013

April 22, 2013

NQMC Update Service: April 22, 2013

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 04/22/2013 12:00 PM EDT

April 22, 2013

New This Week

Measure Summaries

Australian Council on Healthcare Standards

• Aminoglycoside monitoring: percentage of patients with a toxic aminoglycoside concentration whose dosage has been adjusted prior to the next aminoglycoside dose, during the 6 month time period. This updates a previously published measure summary.

• Care planning: percentage of carers involved in developing care plans, during the 6 month time period. This updates a previously published measure summary.

• Care planning: percentage of consumers with current completed care plans (including consumer involvement and signature) in the file, during the 6 month time period. This updates a previously published measure summary.

• Documentation of known adverse drug reactions (ADRs): percentage of patients whose known ADRs are documented on the current medication chart. This updates a previously published measure summary.

• Medication errors: percentage of medication errors resulting in an adverse event requiring intervention beyond routine observation and maintaining, during 6 month time period.

• Medication orders with error-prone abbreviations: percentage of medication orders that include error-prone abbreviations. This updates a previously published measure summary.

• Mental health community: percentage of consumers or nominated carers with 3 or more face-to-face contacts within a 7 day period. This updates a previously published measure summary.

• Mental health community: percentage of consumers or nominated carers with greater than 24 treatment days over a 3 month period. This updates a previously published measure summary.

• Mental health community: percentage of consumers who were admitted to the hospital for psychiatric reasons (by that service) once or more in the first year of treatment. This updates a previously published measure summary.

• Mental health community: percentage of registered consumers seen face-to-face by the community service, during the 6 month time period. This updates a previously published measure summary.

• Reporting mechanisms: percentage of adverse drug reactions which were reported to ACSOM, OMSM, during the 6 month time period.

• Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient who experience abnormal bleeding, during the 6 month time period. This updates a previously published measure summary.

• Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient with an international normalized ratio (INR) reading greater than 5, during the 6 month time period. This updates a previously published measure summary.

• Warfarin management: percentage of patients discharged on warfarin who receive written drug information prior to discharge, during the 6 month time period. This updates a previously published measure summary.

• Warfarin management: percentage of patients on warfarin with an international normalized ratio (INR) result of 4 or above whose dosage has been adjusted or reviewed prior to the next warfarin dose, during the 6 month time period. This updates a previously published measure summary.

• Warfarin management: percentage of patients prescribed hospital-initiated warfarin whose starting doses are consistent with a hospital-approved protocol, during the 6 month time period. This updates a previously published measure summary.